Buy SR-9009 (Stenabolic) Capsules – Next LVL Muscle

Product Overview

SR-9009 Stenabolic Capsules embody a high-grade, brandless research chemical at ≥98% purity, encapsulated for optimal laboratory utility in analytical chemistry and nuclear receptor investigations. Serving as a reference standard, this compound supports examinations of molecular configurations, solubility parameters, and binding characteristics exclusively in controlled in vitro setups. The capsule configuration guarantees accurate dispensing and batch uniformity, empowering qualified researchers with dependable tools for non-clinical protocols.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.​

Chemical Identity & Classification

SR-9009 is cataloged by CAS number 1379686-30-2, affirming its standardized entry in chemical repositories for reliable sourcing. The molecular formula C20H24ClN3O4S equates to a molecular weight of 437.94 g/mol, furnishing precise values for quantitative research designs and instrumental setups. Synonyms such as Stenabolic, REV-ERB Agonist II, and ethyl 3-((((4-chlorophenyl)methyl)((5-nitrothiophen-2-yl)methyl)amino)methyl)pyrrolidine-1-carboxylate denote it as a synthetic analytical reagent and reference material for REV-ERB pathway studies. This categorizes it for in vitro applications handled by expert lab personnel.

Chemical & Physical Characteristics

SR-9009 in capsule form consists of a white to off-white powder core, shielded by inert shells to enable spill-proof laboratory manipulations. It displays solubility exceeding 25 mg/mL in DMSO, up to 20 mg/mL in ethanol, with insolubility in water, informing solvent protocols for assays. Characteristics include a melting point of 79-81°C, predicted boiling point of 547.2°C, density of 1.327 g/cm³, and storage requirements at -20°C due to light sensitivity, which encapsulation partially addresses. These metrics aid in HPLC optimization, LC-MS profiling, and NMR analysis, yielding empirical data for structural validations.

Purity & Analytical Verification

SR-9009 Stenabolic Capsules achieve ≥98% purity per lot, substantiated via HPLC, LC-MS molecular matching, NMR spectroscopy, and residual impurity scans. Controls cap heavy metals at <5 ppm, solvents within ICH limits, and endotoxins below detectable thresholds, satisfying analytical reference demands. Batch Certificates of Analysis (COAs) detail purity assays (>98% typical), spectral overlays, and compliance metrics for institutional records. This verification framework secures consistency for calibration curves and stability assessments.

Quality Control & Batch Integrity

Batch manufacturing assigns distinct lot identifiers tracing from synthesis to encapsulation, preserving provenance integrity. Sequential checks confirm fill accuracy, potency via HPLC, and capsule robustness, with third-party audits for enantiopurity and degradation. Stability profiles validate 24-36 month longevity under refrigeration, retaining samples for audit trails. GMP documentation—including process maps and QC deviations—supports multi-lab collaborations, minimizing variances for serial replications. Rigorous oversight ensures capsule equivalence across productions.

Safety, Handling & Laboratory Precautions

Designated technicians process SR-9009 Capsules in PPE arrays: nitrile barriers, goggles, gowns, and hood ventilation to avert dust. Integrity inspections precede use; compromised units require absorbent isolation and SDS-guided cleanup. GHS07 irritant notations (H315/H319/H335) mandate eyewash access and exposure minimization. Wastes enter hazardous protocols via segregation and thermal destruction, access confined to verified operators. Measures confine risks to lab domains.

Packaging, Labeling & Storage

Capsules package in tamper-proof HDPE or blister units with desiccants blocking moisture and UV exposure. Labels specify CAS 1379686-30-2, C20H24ClN3O4S, ≥98% purity, lot details, and hazard icons per global standards. Store sealed at -20°C desiccated; ambient acclimation prevents clumping, extending viability >2 years. Isolated containment upholds purity.

Intended Research Use & Market Positioning

SR-9009 Stenabolic Capsules equip analytical suites, circadian R&D, metabolic forensics, and academic REV-ERB explorations with dosed precision. They enable IC50 mappings (670 nM REV-ERBα, 800 nM REV-ERBβ), rhythm disruption models, and pathway inhibitions in vitro. As “Next LVL Muscle” grade generics, ≥98% purity optimizes high-volume screens cost-effectively. Core for agonist benchmarking, clock gene repression, and lipid modulator panels in authorized contexts.

Ordering, Availability & Fulfillment

SR-9009 Capsules stock steadily on compliant platforms with encrypted gateways for universal payments. Discreet, tracked despatches arrive 3-7 days via carriers, with COA inclusions. Bulk tiers and support streamline procurement for labs. Fulfillment matches research velocity.

Legal & Regulatory Disclaimer

SR-9009 Stenabolic Capsules (CAS 1379686-30-2) furnish laboratory research exclusively. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Buyers affirm regulatory compliance independently; verification precedes orders.